Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hacene

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Bulletin Du Cancer|November 21, 2000
[Sem: a suitable statistical software adaptated for research in oncology]F Kwiatkowski, M Girard, K Hacene, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Prognostic value of progesterone receptor after long-term follow-up in primary breast cancerM F Pichon, C Pallud, K Hacene, et al.
The International Journal of Biological Markers|July 7, 2000
Is adjuvant tamoxifen recommended in post-menopausal node-negative breast cancer patients with high estrogen receptor values?J L Floiras, K Hacene, F Turpin, et al.
Cancer|November 1, 1990
Predicting distant metastases in operable breast cancer patientsK Hacene, V Le Doussal, J Rouesse, et al.
La Revue Du Praticien|April 1, 1990
[Epidemiologic and prognostic factors of cancer of the breast]J Rouëssé, J Berlie, K Hacene, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1989
Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. A sequential multivariate analysis of 1262 patientsF Spyratos, K Hacene, M Tubiana-Hulin, et al.
Breast Cancer Research and Treatment|January 1, 1990
Survival effect of systemic therapy on patients developing metastatic breast carcinomaJ Rouesse, S Friedman, I Guash-Jordan, et al.
International Journal of Cancer|January 2, 1992
Association between restriction fragment length polymorphism of the L-myc gene and lung metastasis in human breast cancerM H Champeme, I Bieche, A Latil, et al.
Cancer|January 15, 1986
Competitive prognostic value of clinicopathologic and bioimmunologic factors in primary breast cancerK Hacene, A Desplaces, M Brunet, et al.
Cancer|August 15, 1993
Sequential identification of factors predicting distant relapse in breast cancer patients treated by conservative surgeryM Tubiana-Hulin, V Le Doussal, K Hacene, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|November 21, 2000
[Sem: a suitable statistical software adaptated for research in oncology]F Kwiatkowski, M Girard, K Hacene, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Prognostic value of progesterone receptor after long-term follow-up in primary breast cancerM F Pichon, C Pallud, K Hacene, et al.
The International Journal of Biological Markers|July 7, 2000
Is adjuvant tamoxifen recommended in post-menopausal node-negative breast cancer patients with high estrogen receptor values?J L Floiras, K Hacene, F Turpin, et al.
Cancer|November 1, 1990
Predicting distant metastases in operable breast cancer patientsK Hacene, V Le Doussal, J Rouesse, et al.
La Revue Du Praticien|April 1, 1990
[Epidemiologic and prognostic factors of cancer of the breast]J Rouëssé, J Berlie, K Hacene, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1989
Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. A sequential multivariate analysis of 1262 patientsF Spyratos, K Hacene, M Tubiana-Hulin, et al.
Breast Cancer Research and Treatment|January 1, 1990
Survival effect of systemic therapy on patients developing metastatic breast carcinomaJ Rouesse, S Friedman, I Guash-Jordan, et al.
International Journal of Cancer|January 2, 1992
Association between restriction fragment length polymorphism of the L-myc gene and lung metastasis in human breast cancerM H Champeme, I Bieche, A Latil, et al.
Cancer|January 15, 1986
Competitive prognostic value of clinicopathologic and bioimmunologic factors in primary breast cancerK Hacene, A Desplaces, M Brunet, et al.
Cancer|August 15, 1993
Sequential identification of factors predicting distant relapse in breast cancer patients treated by conservative surgeryM Tubiana-Hulin, V Le Doussal, K Hacene, et al.
Pageof 5